Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines
From MaRDI portal
Publication:2105797
DOI10.1007/s00285-022-01828-xzbMath1505.92107OpenAlexW4308769979MaRDI QIDQ2105797
Ernesto A. B. F. Lima, Anna Claudia M. Resende, Thomas E. Yankeelov, Matthew T. McKenna, Regina C. Almeida
Publication date: 8 December 2022
Published in: Journal of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s00285-022-01828-x
Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15) Medical applications (general) (92C50)
Uses Software
Cites Work
- A Bayesian framework for adaptive selection, calibration, and validation of coarse-grained models of atomistic systems
- Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression
- Selection and validation of predictive models of radiation effects on tumor growth based on noninvasive imaging data
- Information criteria and statistical modeling.
- SELECTION AND ASSESSMENT OF PHENOMENOLOGICAL MODELS OF TUMOR GROWTH
- A hybrid ten-species phase-field model of tumor growth
- GENERAL DIFFUSE-INTERFACE THEORIES AND AN APPROACH TO PREDICTIVE TUMOR GROWTH MODELING
- An efficient computational approach for prior sensitivity analysis and cross‐validation
- Model Selection and Multimodel Inference
- Inverse Problem Theory and Methods for Model Parameter Estimation
- 12.1 Continuum Models of Avascular Tumor Growth
- Model Based Inference in the Life Sciences: A Primer on Evidence
This page was built for publication: Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines